CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

GHIT Fund Invests Approx. JPY 140 Million in a Portable Rapid Diagnostic System for Ebola Disease in a Joint Project Between Osaka Metropolitan University, K.K. DNAFORM, and INRB

PartnershipPortable Rapid Diagnostic System for Ebola DiseasePositive
AI Analysis

Summary

GHIT Fund invested JPY 140 million in a joint project by Osaka Metropolitan University, K.K. DNAFORM, and INRB to develop a portable rapid diagnostic system for Ebola disease.

Importance:4/10
Sentiment:
0.50
diagnosticsEbolainvestmentpartnershipportable technology
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on July 23, 2026 4:01 AM

Read Original